MoneyWorks4Me

Ambalal Sarabhai Enterprises informs about unaudited financial results

01 Nov 2019 Evaluate

Ambalal Sarabhai Enterprises has informed that the meeting of the Board of Directors of the Company is scheduled on 14/11/2019, to consider and take on record the unaudited financial results (Standalone and Consolidated) of the Company together with Limited Review Report of Auditors for quarter and half year ended 30.09.2019.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..